Viromed Medical AG (Q11) — Net Asset Momentum
Viromed Medical AG (Q11) recorded a net asset momentum of 212.9% as of December 2024, with net assets of €201.16 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See what is Viromed Medical AG's book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Viromed Medical AG Net Asset Momentum (2021–2024)
This chart tracks Viromed Medical AG's year-over-year net asset growth across 4 annual reporting periods from 2021 to 2024. The most recent momentum reading is +212.9%, with net assets of €201.16 Million EUR as of December 2024. For live market cap and overall valuation, see Q11 stock market capitalisation.
Annual Net Asset History for Viromed Medical AG (2021–2024)
The table below shows the complete annual net asset history for Viromed Medical AG from 2021 to 2024, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Viromed Medical AG tangible equity quality to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €201.16 Million | €255.98 Million | €54.82 Million | ▲ +212.9% |
| 2023 | €64.28 Million | €107.24 Million | €42.96 Million | ▲ +1.7% |
| 2022 | €63.23 Million | €65.10 Million | €1.87 Million | ▲ +58.2% |
| 2021 | €39.97 Million | €42.78 Million | €2.81 Million | — |